Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 6/20 | 0.66 |
| ▸ | CTSK | P43235 | 5/20 | 0.66 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.58 |
| ▸ | MDM4 | O15151 | 1/20 | 0.57 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.54 |
| ▸ | CTSL | P07711 | 1/20 | 0.52 |
| ▸ | CTSB | P07858 | 1/20 | 0.52 |
| ▸ | ESR1 | P03372 | 1/20 | 0.51 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.51 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.50 |
| ▸ | LY96 | Q9Y6Y9 | 1/20 | 0.50 |
| ▸ | ACE | P12821 | 1/20 | 0.50 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.50 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2574440 | 1.00 | CTSS (0.66) | CTSSCTSKKLK5MDM4MDM2 | |
| SCHEMBL539575 | 1.00 | CTSS (0.66) | CTSSCTSKKLK5MDM4MDM2 | |
| SCHEMBL30374091 | 1.00 | CTSS (0.66) | CTSSCTSKKLK5MDM4MDM2 | |
| SCHEMBL22191069 | 0.95 | CTSS (0.67) | CTSSCTSKKLK5MDM4MDM2 | |
| SCHEMBL22191071 | 0.95 | CTSS (0.67) | CTSSCTSKKLK5MDM4MDM2 | |
| SCHEMBL22201737 | 0.95 | CTSS (0.67) | CTSSCTSKKLK5MDM4MDM2 | |
| SCHEMBL309644 | 0.93 | CTSS (0.67) | CTSSCTSKKLK5MDM4MDM2 | |
| SCHEMBL2076110 | 0.93 | CTSS (0.67) | CTSSCTSKKLK5MDM4MDM2 | |
| SCHEMBL14405376 | 0.93 | CTSS (0.67) | CTSSCTSKKLK5MDM4MDM2 | |
| SCHEMBL14884529 | 0.91 | CTSS (0.62) | CTSSCTSKKLK5MDM4MDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 752 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122079925-A | Preparation method of benzothiazole ether compound | — | 2026-05-26 | — | — | CN | claimed |
| CN-120004764-A | Preparation method of amino acid tert-butyl ether | 四川什邡市三高生化实业有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-118388361-A | Formaldehyde reactive unnatural amino acid, preparation method and application thereof | 北京大学深圳研究生院 | 2024-07-26 | — | — | CN | claimed |
| CN-118206565-A | Catalytic marking reagent with phosphatidylserine targeting function and micro-region proteome marking and identifying method | 中国科学院大连化学物理研究所 | 2024-06-18 | — | — | CN | claimed |
| CN-117181306-B | Preparation method of hydrolysis desulfurization bifunctional catalyst for blast furnace gas | 明硕环境科技集团股份有限公司 | 2024-03-15 | — | — | CN | claimed |
| CN-117181306-A | Preparation method of hydrolysis desulfurization bifunctional catalyst for blast furnace gas | 明硕环境科技集团股份有限公司 | 2023-12-08 | — | — | CN | claimed |
| CN-116874487-A | Matrine derivative nano-particles and preparation method and application thereof | 广西大学 | 2023-10-13 | — | — | CN | claimed |
| CN-116726997-A | Preparation method of amino acid functionalized column [5] aromatic hydrocarbon supermolecule chiral catalyst | 广西大学 | 2023-09-12 | — | — | CN | claimed |
| CN-116173908-B | Ferric oxide desulfurizing agent based on modified activated carbon load and preparation method thereof | 明硕环境科技集团股份有限公司 | 2023-07-04 | — | — | CN | claimed |
| CN-116173908-A | Ferric oxide desulfurizing agent based on modified activated carbon load and preparation method thereof | 明硕环境科技集团股份有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-112679400-B | Psamaplin A derivative and preparation method and application thereof | 青岛海洋生物医药研究院股份有限公司 | 2022-10-04 | — | — | CN | claimed |
| CN-112142825-B | Method for synthesizing carbetocin in fragment mode | 山东辰龙药业有限公司 | 2022-03-11 | — | — | CN | claimed |
| CN-109896993-A | The preparation and application of the compound-modified cinnamic acid derivative of new pyridine organic micromolecule | 中国科学院大连化学物理研究所 | 2019-06-18 | — | — | CN | claimed |
| EP-0624599-B1 | Derivatives of mono (6-amino-desoxy)cyclodextrin substituted in position 6 with an alpha aminoacid group, process of their preparation and applications | OREAL (FR) | 1997-07-30 | — | — | EP | claimed |
| CN-122079925-A | Preparation method of benzothiazole ether compound | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260116923-A1 | CYCLIC PEPTIDE IL-1BETA TRAP FOR THE TREATMENT OF ATHEROSCLEROSIS AND INFLAMMATORY DISORDERS | MERCK SHARP & DOHME LLC (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | disclosed |
| US-5081246-A | Isoquinolino sulfonamino derivatives | Hidaka, Hiroyoshi (JP) | 1992-01-14 | — | — | US | disclosed |
| EP-0462531-A2 | Cyclic polypeptide with antibiotic activity, process for its preparation and pure culture of a Coelomycetes strain | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-12-27 | — | — | EP | disclosed |
| EP-0339549-A2 | Tyr-peptide analogs | F. HOFFMANN-LA ROCHE AG (CH) | 1989-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116923-A1 | CYCLIC PEPTIDE IL-1BETA TRAP FOR THE TREATMENT OF ATHEROSCLEROSIS AND INFLAMMATORY DISORDERS | IL1A, IL1B, IL1RN | CTSS 565/4885CTSK 868/4885KLK5 3938/4885 |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | DCLRE1A, CCR3, CCR8 | CTSS 2825/4885CTSK 2135/4885KLK5 4700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.